ESIKA

Manufacturer: Ventura Corporation (San Juan, P.R) | Bel Star S.A. (Colombia)
Effective date: 2011-05-18
Label type: HUMAN OTC DRUG LABEL
Version: 1
Source: legacy-cache
Hydrated at: 2026-08-02 01:51:26

Label at a glance#

ProductESIKA Men Effective Control

Active ingredientPyrithione Zinc

Label structure9 sections

Indications and uses

Helps stop irritation and flaking associated with dandruff:

Dosage and administration

For best results, use at least 2 times a week or as directed by a doctor (or physician).

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

Pyrithione Zinc (0.36%)

Purpose

OTC - PURPOSE SECTION

Antidandruff

Uses

INDICATIONS & USAGE SECTION

Helps stop irritation and flaking associated with dandruff:

Warnings

WARNINGS SECTION

for external use only.

OTC - WHEN USING SECTION

avoid contact with eyes. If contacts occurs, rinse eyes thoroughly with water.

OTC - STOP USE SECTION

if condition worsens or does not improve after regular use of this product as directed, consult a doctor (or physician).

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

For best results, use at least 2 times a week or as directed by a doctor (or physician).

Other information

OTC - ASK DOCTOR SECTION

Ask a doctor before use if you have seborrheic dermatitis that covers a large area of the body.

Inactive ingredients

INACTIVE INGREDIENT SECTION

Aqua (water), sodium laureth sulfate, cocamidopropyl betaine, cocamide dea, dimethiconol , hydrolyzed soy protein, lauryl glucoside, coco-glucoside , glyceryl oleate, sodium chloride, hydrolyzed wheat protein, acrylates/c10-30 alkyl acrylate crosspolymer, triethanolamine, fragrance, guar hydroxypropyltrimonium chloride, glycol distearate, tea-dodecylbenzenesulfonate, tetrasodium edta, ci 77891 (titanium dioxide ), cocamide mea, laureth-10 , magnesium nitrate, citric acid, zinc chloride, butylene glycol, ci 19140 (yellow 5), methylchloroisothiazolinone , magnesium chloride, ppg-26-buteth-26, methylisothiazolinone, peg-40 hydrogenated castor oil, ci 42090 (blue 1), ci 14700 (red 4), apigenin, oleanolic acid, biotinoyl tripeptide-1.

PRINCIPAL DISPLAY PANEL - 300 ml Bottle Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

MEN

shampoo
Effective Control
For all types of hair

> controls symptoms of dandruff
with pyrithione zinc
> Strengthens debilitated hair

ēsika
300 ml e (10.1 fl.oz)

PRINCIPAL DISPLAY PANEL - 300 ml Bottle Label

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
13537-341-01	2025-05-02	C162847	48780-1	960f7f55-d2b3-8e05-e053-dbdaa90a074a	ēsika MEN shampoo Effective Control
13537-341-01	2019-10-29	C162847	48780-1	960f7f55-d2b3-8e05-e053-dbdaa90a074a	ēsika MEN shampoo Effective Control

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
Pyrithione Zinc	ACTIVE INGREDIENT	R953O2RHZ5	1
Pyrithione Zinc	ACTIVE MOIETY	R953O2RHZ5	1
butylene glycol	INACTIVE INGREDIENT	3XUS85K0RA	1
citric acid monohydrate	INACTIVE INGREDIENT	2968PHW8QP	1
cocamidopropyl betaine	INACTIVE INGREDIENT	5OCF3O11KX	1
coco diethanolamide	INACTIVE INGREDIENT	92005F972D	1
coco glucoside	INACTIVE INGREDIENT	ICS790225B	1
coco monoethanolamide	INACTIVE INGREDIENT	C80684146D	1
edetate sodium	INACTIVE INGREDIENT	MP1J8420LU	1
fd&c blue no. 1	INACTIVE INGREDIENT	H3R47K3TBD	1
fd&c red no. 4	INACTIVE INGREDIENT	X3W0AM1JLX	1
fd&c yellow no. 5	INACTIVE INGREDIENT	I753WB2F1M	1
glyceryl monooleate	INACTIVE INGREDIENT	4PC054V79P	1
glycol distearate	INACTIVE INGREDIENT	13W7MDN21W	1
laureth-10	INACTIVE INGREDIENT	BD7AST04GA	1
lauryl glucoside	INACTIVE INGREDIENT	76LN7P7UCU	1
magnesium chloride	INACTIVE INGREDIENT	02F3473H9O	1
magnesium nitrate	INACTIVE INGREDIENT	77CBG3UN78	1
methylchloroisothiazolinone	INACTIVE INGREDIENT	DEL7T5QRPN	1
methylisothiazolinone	INACTIVE INGREDIENT	229D0E1QFA	1
oleanolic acid	INACTIVE INGREDIENT	6SMK8R7TGJ	1
polyoxyl 40 hydrogenated castor oil	INACTIVE INGREDIENT	7YC686GQ8F	1
sodium chloride	INACTIVE INGREDIENT	451W47IQ8X	1
sodium laureth sulfate	INACTIVE INGREDIENT	BPV390UAP0	1
tea-dodecylbenzenesulfonate	INACTIVE INGREDIENT	8HM7ZD48HN	1
titanium dioxide	INACTIVE INGREDIENT	15FIX9V2JP	1
trolamine	INACTIVE INGREDIENT	9O3K93S3TK	1
water	INACTIVE INGREDIENT	059QF0KO0R	1
zinc chloride	INACTIVE INGREDIENT	86Q357L16B	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 29 matching rows.

ESIKA Men Effective Control
Pyrithione Zinc
water
sodium laureth sulfate
cocamidopropyl betaine
coco diethanolamide
lauryl glucoside
coco glucoside
glyceryl monooleate
sodium chloride
trolamine
glycol distearate
tea-dodecylbenzenesulfonate
edetate sodium
titanium dioxide
coco monoethanolamide
laureth-10
magnesium nitrate
citric acid monohydrate
zinc chloride
butylene glycol
fd&c yellow no. 5
methylchloroisothiazolinone
magnesium chloride
methylisothiazolinone
polyoxyl 40 hydrogenated castor oil
fd&c blue no. 1
fd&c red no. 4
oleanolic acid

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
13537-341	13537-341-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 28 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
Pyrithione Zinc	R953O2RHZ5	ACTIB
water	059QF0KO0R	IACT
sodium laureth sulfate	BPV390UAP0	IACT
cocamidopropyl betaine	5OCF3O11KX	IACT
coco diethanolamide	92005F972D	IACT
lauryl glucoside	76LN7P7UCU	IACT
coco glucoside	ICS790225B	IACT
glyceryl monooleate	4PC054V79P	IACT
sodium chloride	451W47IQ8X	IACT
trolamine	9O3K93S3TK	IACT
glycol distearate	13W7MDN21W	IACT
tea-dodecylbenzenesulfonate	8HM7ZD48HN	IACT
edetate sodium	MP1J8420LU	IACT
titanium dioxide	15FIX9V2JP	IACT
coco monoethanolamide	C80684146D	IACT
laureth-10	BD7AST04GA	IACT
magnesium nitrate	77CBG3UN78	IACT
citric acid monohydrate	2968PHW8QP	IACT
zinc chloride	86Q357L16B	IACT
butylene glycol	3XUS85K0RA	IACT
fd&c yellow no. 5	I753WB2F1M	IACT
methylchloroisothiazolinone	DEL7T5QRPN	IACT
magnesium chloride	02F3473H9O	IACT
methylisothiazolinone	229D0E1QFA	IACT
polyoxyl 40 hydrogenated castor oil	7YC686GQ8F	IACT
fd&c blue no. 1	H3R47K3TBD	IACT
fd&c red no. 4	X3W0AM1JLX	IACT
oleanolic acid	6SMK8R7TGJ	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 7 · 396 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
trolamine	TROLAMINE	9O3K93S3TK	INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS	0.02 %w/v		Exact identifier — unii candidate 22 equally ranked IID candidates
fd&c blue no. 1	FD&C BLUE NO. 1	H3R47K3TBD	MOUTHWASH / BUCCAL	NA		Exact identifier — unii candidate 37 equally ranked IID candidates
citric acid monohydrate	CITRIC ACID MONOHYDRATE	2968PHW8QP	EMULSION / TOPICAL	0.11 %w/w		Exact identifier — unii candidate 88 equally ranked IID candidates
sodium chloride	SODIUM CHLORIDE	451W47IQ8X	INJECTION / INTRATHECAL		9 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
zinc chloride	ZINC CHLORIDE	86Q357L16B	SOLUTION/ DROPS / OPHTHALMIC	NA		Exact identifier — unii candidate 5 equally ranked IID candidates
sodium chloride	SODIUM CHLORIDE	451W47IQ8X	INJECTION / INFILTRATION		648 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
citric acid monohydrate	CITRIC ACID MONOHYDRATE	2968PHW8QP	INJECTION / INTRACARDIAC	1.05 %w/v		Exact identifier — unii candidate 88 equally ranked IID candidates
fd&c yellow no. 5	FD&C YELLOW NO. 5	I753WB2F1M	TABLET, DELAYED RELEASE / ORAL		3 mg	Exact identifier — unii candidate 22 equally ranked IID candidates
glyceryl monooleate	GLYCERYL OLEATE	4PC054V79P	CREAM, AUGMENTED / TOPICAL	3.5 %w/w		Exact identifier — unii candidate 7 equally ranked IID candidates
titanium dioxide	TITANIUM DIOXIDE	15FIX9V2JP	CAPSULE / ORAL		72 mg	Exact identifier — unii candidate 40 equally ranked IID candidates
sodium chloride	SODIUM CHLORIDE	451W47IQ8X	INJECTION, SUSPENSION, LIPOSOMAL / EPIDURAL		11 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
edetate sodium	EDETATE SODIUM	MP1J8420LU	EMULSION / OPHTHALMIC	0.02 %w/v		Exact identifier — unii candidate 12 equally ranked IID candidates
citric acid monohydrate	CITRIC ACID MONOHYDRATE	2968PHW8QP	POWDER, FOR SUSPENSION / ORAL		840 mg	Exact identifier — unii candidate 88 equally ranked IID candidates
fd&c blue no. 1	FD&C BLUE NO. 1	H3R47K3TBD	LOTION / TOPICAL	NA		Exact identifier — unii candidate 37 equally ranked IID candidates
trolamine	TROLAMINE	9O3K93S3TK	SPRAY / NASAL	NA		Exact identifier — unii candidate 22 equally ranked IID candidates
titanium dioxide	TITANIUM DIOXIDE	15FIX9V2JP	SUPPOSITORY, EXTENDED RELEASE / INTRAUTERINE	1 mg		Exact identifier — unii candidate 40 equally ranked IID candidates
citric acid monohydrate	CITRIC ACID MONOHYDRATE	2968PHW8QP	SYRUP / ORAL	722 mg/5ml		Exact identifier — unii candidate 88 equally ranked IID candidates
fd&c blue no. 1	FD&C BLUE NO. 1	H3R47K3TBD	TABLET, DELAYED RELEASE / ORAL	0.01 mg		Exact identifier — unii candidate 37 equally ranked IID candidates
fd&c yellow no. 5	FD&C YELLOW NO. 5	I753WB2F1M	OINTMENT / TOPICAL	0.01 %w/w		Exact identifier — unii candidate 22 equally ranked IID candidates
sodium chloride	SODIUM CHLORIDE	451W47IQ8X	TABLET, DELAYED RELEASE / ORAL		97 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
fd&c blue no. 1	FD&C BLUE NO. 1	H3R47K3TBD	DOUCHE / VAGINAL	NA		Exact identifier — unii candidate 37 equally ranked IID candidates
sodium chloride	SODIUM CHLORIDE	451W47IQ8X	INJECTION, SOLUTION / SUBARACHNOID	0.9 %w/v		Exact identifier — unii candidate 134 equally ranked IID candidates
fd&c yellow no. 5	FD&C YELLOW NO. 5	I753WB2F1M	POWDER / TOPICAL	NA		Exact identifier — unii candidate 22 equally ranked IID candidates
citric acid monohydrate	CITRIC ACID MONOHYDRATE	2968PHW8QP	INJECTION / INFILTRATION	0.02 %w/v		Exact identifier — unii candidate 88 equally ranked IID candidates
fd&c yellow no. 5	FD&C YELLOW NO. 5	I753WB2F1M	SYRUP / ORAL	0.1 mg		Exact identifier — unii candidate 22 equally ranked IID candidates
sodium chloride	SODIUM CHLORIDE	451W47IQ8X	POWDER, FOR SOLUTION / OPHTHALMIC	0.9 %w/w		Exact identifier — unii candidate 134 equally ranked IID candidates
citric acid monohydrate	CITRIC ACID MONOHYDRATE	2968PHW8QP	CONCENTRATE / ORAL	5.3 mg/1ml		Exact identifier — unii candidate 88 equally ranked IID candidates
sodium chloride	SODIUM CHLORIDE	451W47IQ8X	INJECTION / INTRACARDIAC		70 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
sodium chloride	SODIUM CHLORIDE	451W47IQ8X	SOLUTION / INTRAVENOUS		90 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
sodium chloride	SODIUM CHLORIDE	451W47IQ8X	INJECTION, POWDER, FOR SOLUTION / INTRATHECAL	1.35 mg		Exact identifier — unii candidate 134 equally ranked IID candidates
sodium chloride	SODIUM CHLORIDE	451W47IQ8X	INJECTION / INTRAVENOUS		28773 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
citric acid monohydrate	CITRIC ACID MONOHYDRATE	2968PHW8QP	INJECTION / INTRAVENOUS	2068 mg		Exact identifier — unii candidate 88 equally ranked IID candidates
trolamine	TROLAMINE	9O3K93S3TK	GEL, METERED / TRANSDERMAL		14 mg	Exact identifier — unii candidate 22 equally ranked IID candidates
citric acid monohydrate	CITRIC ACID MONOHYDRATE	2968PHW8QP	INJECTION / EPIDURAL	0.02 %w/v		Exact identifier — unii candidate 88 equally ranked IID candidates
fd&c blue no. 1	FD&C BLUE NO. 1	H3R47K3TBD	PASTE, DENTIFRICE / DENTAL	NA		Exact identifier — unii candidate 37 equally ranked IID candidates
edetate sodium	EDETATE SODIUM	MP1J8420LU	SOLUTION / OPHTHALMIC	0.1 %w/v		Exact identifier — unii candidate 12 equally ranked IID candidates
sodium chloride	SODIUM CHLORIDE	451W47IQ8X	SUSPENSION / AURICULAR (OTIC)	0.9 %w/v		Exact identifier — unii candidate 134 equally ranked IID candidates
sodium chloride	SODIUM CHLORIDE	451W47IQ8X	POWDER, DENTIFRICE / DENTAL	0.03 mg/mg		Exact identifier — unii candidate 134 equally ranked IID candidates
sodium chloride	SODIUM CHLORIDE	451W47IQ8X	INJECTION, SOLUTION, CONCENTRATE / INTRAMUSCULAR	0.86 %w/v		Exact identifier — unii candidate 134 equally ranked IID candidates
zinc chloride	ZINC CHLORIDE	86Q357L16B	INJECTION / INTRADERMAL	7 mg		Exact identifier — unii candidate 5 equally ranked IID candidates
titanium dioxide	TITANIUM DIOXIDE	15FIX9V2JP	SHAMPOO, SUSPENSION / TOPICAL	3 %w/v		Exact identifier — unii candidate 40 equally ranked IID candidates
citric acid monohydrate	CITRIC ACID MONOHYDRATE	2968PHW8QP	LIQUID / INTRAVENOUS	0.2 %w/v		Exact identifier — unii candidate 88 equally ranked IID candidates
citric acid monohydrate	CITRIC ACID MONOHYDRATE	2968PHW8QP	TABLET, FILM COATED / ORAL		42 mg	Exact identifier — unii candidate 88 equally ranked IID candidates
butylene glycol	BUTYLENE GLYCOL	3XUS85K0RA	SYSTEM / TOPICAL		1400 mg	Exact identifier — unii candidate 2 equally ranked IID candidates
citric acid monohydrate	CITRIC ACID MONOHYDRATE	2968PHW8QP	LOTION / TOPICAL	0.85 %w/w		Exact identifier — unii candidate 88 equally ranked IID candidates
fd&c yellow no. 5	FD&C YELLOW NO. 5	I753WB2F1M	TABLET, EXTENDED RELEASE / ORAL	2.03 mg		Exact identifier — unii candidate 22 equally ranked IID candidates
trolamine	TROLAMINE	9O3K93S3TK	GEL / TRANSDERMAL		6 mg	Exact identifier — unii candidate 22 equally ranked IID candidates
sodium chloride	SODIUM CHLORIDE	451W47IQ8X	SOLUTION / INTRAVASCULAR	NA		Exact identifier — unii candidate 134 equally ranked IID candidates
citric acid monohydrate	CITRIC ACID MONOHYDRATE	2968PHW8QP	SOLUTION / NASAL	2.8 mg/1ml		Exact identifier — unii candidate 88 equally ranked IID candidates
sodium chloride	SODIUM CHLORIDE	451W47IQ8X	SUSPENSION / RESPIRATORY (INHALATION)		43 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
fd&c yellow no. 5	FD&C YELLOW NO. 5	I753WB2F1M	ELIXIR / ORAL	0.15 mg		Exact identifier — unii candidate 22 equally ranked IID candidates
citric acid monohydrate	CITRIC ACID MONOHYDRATE	2968PHW8QP	SOLUTION / INTRAVENOUS		10 mg	Exact identifier — unii candidate 88 equally ranked IID candidates
citric acid monohydrate	CITRIC ACID MONOHYDRATE	2968PHW8QP	ELIXIR / ORAL	100 mg/5ml		Exact identifier — unii candidate 88 equally ranked IID candidates
titanium dioxide	TITANIUM DIOXIDE	15FIX9V2JP	GEL / TOPICAL	0.06 %w/w		Exact identifier — unii candidate 40 equally ranked IID candidates
fd&c blue no. 1	FD&C BLUE NO. 1	H3R47K3TBD	TABLET / SUBLINGUAL	0.03 mg		Exact identifier — unii candidate 37 equally ranked IID candidates
citric acid monohydrate	CITRIC ACID MONOHYDRATE	2968PHW8QP	INJECTION / INTRASYNOVIAL	ADJ PH		Exact identifier — unii candidate 88 equally ranked IID candidates
fd&c blue no. 1	FD&C BLUE NO. 1	H3R47K3TBD	FILM, SOLUBLE / ORAL	0.04 mg		Exact identifier — unii candidate 37 equally ranked IID candidates
sodium chloride	SODIUM CHLORIDE	451W47IQ8X	INJECTION / INTRAMUSCULAR		1486 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
coco diethanolamide	COCO DIETHANOLAMIDE	92005F972D	CREAM / TOPICAL		30 mg	Exact identifier — unii candidate 5 equally ranked IID candidates
sodium laureth sulfate	SODIUM LAURETH-3 SULFATE	BPV390UAP0	CAPSULE / ORAL	3.5 mg		Exact identifier — unii candidate 5 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
3429d66a-6610-f72d-e063-6394a90a0147			9d727f07-12de-4477-867e-a6cc44fc5192	2025-05-02	Warnings	Exact identifier spl set id: 9d727f07-12de-4477-867e-a6cc44fc5192

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.